Status:
COMPLETED
MagneThermoPro : Magnetic Resonance Thermography of Human Prostate
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Prostate Cancer Diagnosis
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The objective of this project is to offer a very innovative solution for measuring temperature variations in MRI on the prostate. Multiparametric prostate MRI can detect target lesions, on which targe...
Detailed Description
Prostate MRI has become the benchmark examination to search for tumor targets, thanks to a multi-parameter protocol, including T2 sequences, diffusions, and T1 with gadolinium injection. A PIRADS prog...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old
- Patient with indication of injected multi-parameter MRI for the diagnosis of prostate cancer.
- Signed informed consent.
- Person affiliated or beneficiary of health insurance
Exclusion
- MRI contraindications (Pace Maker, metallic foreign body, metallic heart valve).
- Contraindication to gadolinium salt,
- Patient under legal protection
Key Trial Info
Start Date :
July 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 8 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04822272
Start Date
July 8 2022
End Date
June 8 2023
Last Update
January 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Bordeaux
Bordeaux, France